Albuterol: Difference between revisions
imported>Howard C. Berkowitz (New page: '''Albuterol''' is a short-acting adrenergic beta-agonist, widely used in the immediate treatment of symptomatic asthma and other respiratory diseases. It is a "racemic mixture wit...) |
mNo edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
'''Albuterol''' is a short-acting [[adrenergic beta-agonist]], widely used in the immediate treatment of symptomatic [[asthma]] and other respiratory diseases. It is a "racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol, with the chemical name 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol. <ref>{{MeSH}}</ref> | '''Albuterol''' is a short-acting [[adrenergic beta-agonist]], widely used in the immediate treatment of symptomatic [[asthma]] and other respiratory diseases. It is a "racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol, with the chemical name 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol. <ref>{{MeSH}}</ref> | ||
| Line 8: | Line 9: | ||
| journal = Medscape Drug Information | | journal = Medscape Drug Information | ||
| title = Albuterol Inh[aled]}}</ref> | | title = Albuterol Inh[aled]}}</ref> | ||
*Acute | *Acute [[asthma]] attack | ||
*Asthma | *Asthma prevention | ||
*Bronchitis | *[[Bronchitis]] | ||
*Bronchospasm | *[[Bronchospasm]] revention | ||
*Bronchospastic | *Bronchospastic pulmonary disease | ||
*Exercise- | *[[Exercise-induced asthma]] | ||
* | *obstructive pulmonary disease | ||
* | *[[Emphysema]] | ||
Off-label uses include: [[hyperkalemia]], [[familial hyperkalemic periodic paralysis]], and respiratory distress in neonates. | Off-label uses include: [[hyperkalemia]], [[familial hyperkalemic periodic paralysis]], and respiratory distress in neonates. | ||
| Line 24: | Line 25: | ||
| journal = Medscape Drug Information}}</ref> | | journal = Medscape Drug Information}}</ref> | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}}[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:00, 8 July 2024
Albuterol is a short-acting adrenergic beta-agonist, widely used in the immediate treatment of symptomatic asthma and other respiratory diseases. It is a "racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol, with the chemical name 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol. [1]
While most often administered through the respiratory tract using a metered dose inhaler or nebulizer, it also can be given orally.
Uses
Approved indications for the inhaled form include:[2]
- Acute asthma attack
- Asthma prevention
- Bronchitis
- Bronchospasm revention
- Bronchospastic pulmonary disease
- Exercise-induced asthma
- obstructive pulmonary disease
- Emphysema
Off-label uses include: hyperkalemia, familial hyperkalemic periodic paralysis, and respiratory distress in neonates.
Drug comparisons
While it is considered short-acting, its duration of action is longer isoproterenol, is less likely to cause cardiac effects, and as at least as effective as a bronchodilator. [3]
References
- ↑ Anonymous (2024), Albuterol (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ "Albuterol Inh[aled]", Medscape Drug Information
- ↑ "Monograph: Albuterol", Medscape Drug Information